Taiwan-listed biotech company Royal King held a board election today that has quickly become embroiled in controversy. A shareholder group identified as the “market faction” alleges irregularities in the vote count, specifically claiming that handwritten vote tallies were altered to change the list of elected directors. The group accuses the existing board of manipulating the results to maintain control. Royal King has yet to officially respond to the allegations, but the claims have sparked concern among investors. The dispute centers around discrepancies between initial counts and the final announced results. Further investigation is expected to determine the validity of the election and the accuracy of the vote tally. The situation could potentially lead to legal challenges and impact the company’s future direction.